Introduction
Hepatitis C virus is a spherical, enveloped, single stranded RNA virus.( I ) Six major HCV genotypes and more than 90 subtypes have been identified based on molecular relatedness.(2) Genotype 1,2 &3 have a worldwide distribution, while genotype 4,5&6 are localized to specific geographic location. (3) In Egypt, HCV is a major cause of liver disease & leading cause of death, with an estimated HCV infection rate of 15% to 20%. Egypt has a higher incidence of HCV infection than any other country in the world.(4) Most Egyptian cases of HCV are due to genotype S, which is uncommon in the west. (5) Diagnosis of HCV infection involves the presence of the virus and assessment of the severity of liver infection. The diagnosis workup should include investigations that may help to predict prognosis and response to treatment. Diagnosis of chronic HCV infection based upon the presence of elevated serum aminotransferase and anti-HCV antibodies or the presence of HCV RNA in the serum. The disease is said to be chronic if amniotransferases were elevated for more than 6 months or the liver biopsy shows chronic pathological changes of hepatitis. (6) 
Aim of the work
The aim of this work was to detect the prevalence of hepatitis C virus infection among pregnant women and their neonates at El-Shatby maternity university hospital.
Patients
This work is a random cross-sectional study performed at El-Shatby maternity university hospital in Alexandria, Egypt. The study was conducted over one thousand pregnant females in the third trimester attending for labor. Counseling and explanation of all aspects of the study to the participants and their consent was taken prior to their participation. Withdrawal of the samples started in May and ended in December 2005 with the completion of the one thousand cases included in the study. There were no exclusion criteria in this study.
Methods
All patients were subjected to the following:
1. Full history taking including:
• Personal history: age, occupation, residence and special habits.
• History of medical illness: diabetes, liver disease & or treatment
• Surgical history: previous surgery & or blood transfusion.
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• History of dental manipulation & tattooing.
• Positive family history of liver diseases and any relevant history.
• Obstetrical & gynecological history.
Complete general examination.
3. Complete obstetrical examination.
Blood sampling and laboratory analysis:
Blood samples (3m1 each) were withdrawn from the pregnant females & umbilical cord of their neonates. Sera were separated by centrifugation and stored at (-20°C) till testing time. At that time the sera were taken out of the freezer, left to thaw, remixed and centrifuged.
The supernatant of the maternal samples were tested for hepatitis C antibodies using enzyme linked immunosorbent assay (ELISA).
The supernatant of the neonates of HCV-Antibodies positive mothers were tested for HCV-Antibodies by enzyme linked immunosorbent assay (ELISA).
HCV-Antibodies positive samples were examined for liver function tests namely:
(a) ALT (serum alanine aminotransferase). (b) AST (serum aspartate aminotransferase).
Fifty HCV-Antibodies negative cases were examined for liver function tests as a control group.
Results
In this study a total number of one thousand pregnant females in the third trimester were randomly selected from attendance of shatby maternity university hospital for delivery, they were screened for hepatitis C virus infection using the third generation ELISA. Blood samples were taken from the selected cases and the umbilical cord of their neonates immediately after birth, the umbilical cord blood samples of the HCV-Ab's positive mothers were investigated for the presence of HCV-Ab's. 
According to age group
The mean age of the studied sample was 26.61 years ranging from 16 to 40 years with the highest frequency seen in the 25 to less than 30 years segment amounting to 35.5% of the whole sample. Forty five pregnant females were tested positive for HCV-Ab's. The mean age of the HCV-Ab's positive mothers were 27.56 years ranging from 16 to 40 with the highest frequency seen in the 20 to less than 25 years segment representing 33.3% of the HCV-Ab's positive group. The number of the primigravidae was 347 of the studied sample 34.7% and 11 of them tested positive for HCV representing 24.4% of the HCV-positive cases. On the other hand, the number of multigravidae was 653 and 34 of them tested positive for HCV with the highest frequency seen in multigravidae 2 to 4 making 62.3% of the HCV-positive cases. The mean vidity among the studied sample was 2.50 ranging from I to 12. On the other hand, the mean gravidity among the HCV-Ab's positive cases was 3.11 as compared to 2.47 among the non infected cases. X2=Chi square, P=probability, NS=non significant, OR=odds ratio, CI=confidence interval A total number of 981 pregnant females of the studied sample delivered normal living babies with no congenital fetal malformations and 45 of them tested positive for HCV-Ab's. X2=Chi square, P=probability, *=significant difference, OR=odds ratio, CI-confidence interval 92 pregnant females of the studied sample 9.2% gave history of at least one episode of transfusion of blood or blood products and 13 of them tested positive for HCV-Ab's representing 28.9% of the HCV-positive cases as compared to 8.3% of the HCV-negative group, i.e. nearly about one third of the infected individuals received at least a single transfusion of blood or blood products. V.-Chi square, P=probability, NS=non significant, *=significant difference, OR=odds ratio, CI=confidence interval *some cases had more than one operative intervention. A total number of 793 pregnant females had a positive history of previous operative intervention regardless the indications, representing 79.3% of the studied sample. Around 179 of the studied population 17.9% gave a history of either cesarean section or assisted delivery using forceps or ventose and 8 of them tested positive for HCV representing 17.8% of the HCV-positive cases. ON the other hand, 22.2% gave a history of at least one episode of invasive gynecologic procedure including laparoscopy, dilatation and curettage and a variety of major gynecologic surgeries including myomectomies and repair procedures and 10 of them tested positive for HCV representing 22.2% of the HCV-Ab's positive cases. Finally, 392 of the tested females 39.2% had other surgical (non-obstetric, non-gynecologic) operations ranging from tonsillectomy, appendectomy to hernia repair and thyroidectomy and 27 of them tested positive for HCV representing 60% of the HCV-Ab's positive cases. X2=Chi square, P=probability, NS=non significant, *-significant difference, OR=odds ratio, CI=confidence interval Certain factors were shown to be associated with a high prevalence of HCV-Ab's. History of previous dental procedures were positively correlated with a high prevalence of HCV-Ab's; around 16.3% of the studied females gave a history of a t least one dental visit and 30 of them tested positive for HCV-Ab's representing 66.7% of the HCV-positive cases as compared to 13.9% of the HCV-negative group; this difference is statistically significant. On the other hand, the difference between infected and non-infected individuals as regards history of unsafe injection using non-disposable syringe was not statistically significant. Fifty four pregnant females of the studied sample gave a history of bilharziasis and treatment; 47 of them were treated with oral therapy and non-of them tested positive for HCV. On the other hand, 7 pregnant females were treated with parenteral therapy and 4 of them tested positive for HCV representing 8.9% of the HCV-Ab's positive cases as compared to 0.3% of the HCV-negative cases; this difference was statistically significant. Only 6 of the whole studied population gave a history of a high risk occupation including nurses, healthcare workers, employees in laboratories & dialysis units and 2 of them tested positive for tested positive for HCV representing 4.4% of the HCV-positive cases as compared to 0.4% of the HCV-negative cases; this difference was also statistically significant. On doing multiple regression analysis (=multivariate analysis) using linear model it was found that history of blood transfusion, previous obstetric operations, previous gynecologic operations, previous surgical operations, dental procedures, unsafe injections using un-disposable syringes, high risk occupations as well as parenteral therapy for bilharziasis were all statistically significant risk factors for HCV. 
Discussion
Hepatitis C virus is a major health problem throughout the world. It is estimated that 3% or nearly about one hundred and seventy million people worldwide are HCV antibodies positive; of those, 35% are women in childbearing period. (7) Our work is cross sectional study depending on the screening of blood samples withdrawn from one thousand pregnant women and their neonates immediately after birth. The withdrawn samples were screened for the presence of HXC antibodies using the 3rd generation ELISA technique.
The results of this study revealed that the seroprevalence rate of HCV antibodies among all the tested pregnant females were 4.5%. This goes with the most of the United States and international studies that reported that the seroprevalence rate of HCV antibodies among the pregnant women to be between 0.7 and 4.4%. (8,9,10) Umbilical cord samples of the HCV antibodies positive mothers were all HCV antibodies positive at birth. Further confirmation of these results is by detection of HCV-RNA using the PCR. (11) In 1994, a prospective study was performed in blood transfusion service, Fukushima medical college, Japan, to assess the vertical transmission of HCV. It included 7698 parturient women. They were tested for anti HCV antibodies; 53 were positive and 31 of them only were HCV-RNA positive. The 54 infants of the HCV antibodies positive mothers (including one st of twins) were HCV antibodies positive at birth and were followed for 6 months. In 2005, two separate studies were done to estimate the vertical transmission of HCV and investigate the effect of mode of delivery and infant feed in on the risk of HCV transmission. In the 1st study, the overall rate of vertical transmission from mothers who wee HCV RNA positive at delivery was 4.7%. In the 2nd study, the overall rate of HCV vertical transmission was 6.2%. Membrane rupture for more than 6 hours and internal fetal monitoring were associated with transmission of HCV to infants in both studies. (14) In our study, the HCV antibodies positive cases were increased with age and gravidity. This may be attributed to increased exposure to other risk factors as increased operative interference and transfusion of blood and blood products. Nearly one third of the HCV antibodies positive mothers (28.9%) received at least a single transfusion of blood or blood products. This is in agree with Arthur et al (1997) who reported a rate of 24.8% among blood donors from different Egyptian governorates. (4) As regards the fetal outcome in our study, all the neonates of the HCV positive mothers were normal, with no congenital anomalies. This is in agreement with Kudo T (1997) who reported no association between maternal HCV infection with abortion, still birth, premature birth or congenital anomalies. (15) In the present study, there were no significant difference between HCV antibodies positive cases and the control group as regards liver enzymes. This goes with Gervais et al (2000) . (16) .
